Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Frailty and COVID-19 mRNA Vaccine Antibody Response in the COVID-19 Community Research Partnership

The Journals of Gerontology Series A(2022)10.1093/gerona/glac095Source: DataRank Database

Frailty and COVID-19 mRNA Vaccine Antibody Response in the COVID-19 Community Research Partnership is a research paper published in The Journals of Gerontology Series A (2022). On theSindex it has a DataRank of 0. It has been cited 33 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access33 citations

Download PDF

Cite:

Linked data & code

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (7 grants)Impact (FWCI 3.97)OA: greenTopics (42)Linked Datasets (12)DataCite Reuse (12)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (2/2)

Has DOI
Indexed in repositories

Accessible (1/2)

Open Access

Interoperable (2/2)

DataCite relations
Linked datasets

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Michael DeWitt ORCID,Kathryn E. Callahan ORCID,David M. Herrington ORCID,Martha A. Alexander‐Miller ORCID,Joshua Yukich ORCID

Live enrichment

PubMed:35446945 PMC:PMC9047234 OpenAlex:https://openalex.org/W4224212086

National Institutes of Health

Grant: 5T32AG033534-12

Training Program in Gerontological and Geriatric Research

National Institutes of Health

Grant: UL1TR001420

National Institute of Aging

Grant: K76-AG059986

NIA NIH HHS

Grant: K76 AG059986

NIA NIH HHS

Grant: T32 AG033534

National Institutes of Health

Grant: 5K76AG059986-04

Identifying Frailty in Primary Care: Implementation of an Electronic Medical Record-based Frailty Index

National Institutes of Health

Grant: 1UL1TR001420-01

Wake forest Clinical and Translational Science Award

FWCI

3.97

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

greenLicense: OUP Standard Publication Reuse

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9047234

publisherhttps://academic.oup.com/biomedgerontology/advance-article-pdf/doi/10.1093/gerona/glac095/43892308/glac095.pdf

publisherhttps://academic.oup.com/biomedgerontology/article-pdf/77/7/1366/44412857/glac095.pdf

journalhttps://doi.org/10.1093/gerona/glac095

Fields of Study

Frailty in Older AdultsSARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations03 medical and health sciences0302 clinical medicine

MeSH Terms

FrailtyCOVID-19COVID-19 VaccinesmRNA VaccinesAgedAntibody FormationHumansVaccines, SyntheticFrail Elderly

Keywords

Coronavirus disease 2019 (COVID-19)2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyGeneral partnershipPandemicAntibody responseBiologyComputational biologyAntibodyMedicineImmunologyPolitical scienceInfectious disease (medical specialty)DiseaseOutbreakInternal medicineImmune functionFrailtyCovid-19Vaccines, SyntheticCOVID-19 VaccinesFrail ElderlyAntibody FormationTHE JOURNAL OF GERONTOLOGY: Medical SciencesHumansmRNA VaccinesAged

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Partnerships for the goals

Additional file 1 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631586.v1figshare

Additional file 1 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631586figshare

Additional file 2 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631589.v1figshare

Additional file 2 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631589figshare

Additional file 3 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631592.v1figshare

Additional file 3 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631592figshare

Additional file 4 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631595.v1figshare

Additional file 4 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631595figshare

Additional file 5 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631598.v1figshare

Additional file 5 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631598figshare

Additional file 6 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631601.v1figshare

Additional file 6 of Potential determinants of antibody responses after vaccination against SARS-CoV-2 in older persons: the Doetinchem Cohort Study

10.6084/m9.figshare.26631601figshare